13F

ANIK ANIKA THERAPEUTICS INC

2026Q1 · CUSIP 035255108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
129
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
71
Δ whales
+1
Inst. holding value
$179M
New positions
24
Closed positions
21
Price momentum (1Q)
+43.5%
Put / Call
0/1

Breadth history (34 quarters)

2018Q1: Δ-2 · h=171 2018Q2: Δ-2 · h=169 2018Q3: Δ-7 · h=162 2018Q4: Δ+1 · h=163 2019Q1: Δ-5 · h=158 2019Q2: Δ+7 · h=165 2019Q3: Δ+32 · h=197 2019Q4: Δ-4 · h=193 2020Q1: Δ-32 · h=161 2020Q2: Δ-5 · h=156 2020Q3: Δ+0 · h=156 2020Q4: Δ+8 · h=164 2021Q1: Δ-18 · h=146 2021Q2: Δ-4 · h=142 2021Q3: Δ-10 · h=132 2021Q4: Δ-4 · h=128 2022Q1: Δ-10 · h=118 2022Q2: Δ+11 · h=129 2022Q3: Δ-6 · h=123 2022Q4: Δ+3 · h=126 2023Q1: Δ-6 · h=120 2023Q2: Δ-2 · h=118 2023Q3: Δ+0 · h=118 2023Q4: Δ+0 · h=118 2024Q1: Δ+3 · h=121 2024Q2: Δ-6 · h=115 2024Q3: Δ+8 · h=123 2024Q4: Δ-12 · h=111 2025Q1: Δ-2 · h=109 2025Q2: Δ-5 · h=104 2025Q3: Δ+12 · h=116 2025Q4: Δ+10 · h=126 2026Q1: Δ+3 · h=129 2018Q1: holders=171 2018Q2: holders=169 2018Q3: holders=162 2018Q4: holders=163 2019Q1: holders=158 2019Q2: holders=165 2019Q3: holders=197 2019Q4: holders=193 2020Q1: holders=161 2020Q2: holders=156 2020Q3: holders=156 2020Q4: holders=164 2021Q1: holders=146 2021Q2: holders=142 2021Q3: holders=132 2021Q4: holders=128 2022Q1: holders=118 2022Q2: holders=129 2022Q3: holders=123 2022Q4: holders=126 2023Q1: holders=120 2023Q2: holders=118 2023Q3: holders=118 2023Q4: holders=118 2024Q1: holders=121 2024Q2: holders=115 2024Q3: holders=123 2024Q4: holders=111 2025Q1: holders=109 2025Q2: holders=104 2025Q3: holders=116 2025Q4: holders=126 2026Q1: holders=129 -32 -16 +0 +16 +32 93150207 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q2 Top 13% +33.2% +33.5%
2019Q3 Top 3% -30.1% -44.8%
2019Q2 Top 19% +6.3% -24.6%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.79
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
-0.7%
Quarterly Revenue & EPS (4Y)
2022-06-30: $40M 2022-09-30: $40M 2022-12-31: $-3M 2023-03-31: $38M 2023-06-30: $44M 2023-09-30: $41M 2023-12-31: $-3M 2024-03-31: $29M 2024-06-30: $31M 2024-09-30: $30M 2024-12-31: $31M 2025-03-31: $26M 2025-06-30: $28M 2025-09-30: $28M 2025-12-31: $31M 2026-03-31: $30M 2022-06-30: EPS -0.20 2022-09-30: EPS -0.29 2022-12-31: EPS -0.33 2023-03-31: EPS -0.71 2023-06-30: EPS -0.19 2023-09-30: EPS -0.45 2023-12-31: EPS -4.29 2024-03-31: EPS -0.31 2024-06-30: EPS 0.00 2024-09-30: EPS -2.03 2024-12-31: EPS -1.49 2025-03-31: EPS -0.34 2025-06-30: EPS -0.28 2025-09-30: EPS -0.16 2025-12-31: EPS 0.02 2026-03-31: EPS -0.37 0M 22M 44M $M -4.72 -2.35 0.02 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)